Antibody to myelin-associated glycoprotein produces central nervous system demyelination

Neurology. 1988 Mar;38(3):422-6. doi: 10.1212/wnl.38.3.422.

Abstract

Antibodies to myelin-associated glycoprotein (MAG) have been implicated in certain human demyelinating diseases of the peripheral nervous system. In the present study, a monoclonal antibody to MAG with 20% guinea pig serum (GPS) was injected into mammalian optic nerves and produced in vivo demyelination associated with three ultrastructural patterns of myelin injury: (1) widened lamellae; (2) myelin vesiculation; and (3) cell-associated myelin damage. These patterns of myelin injury have been observed neuropathologically in MS and in a demyelinating peripheral neuropathy associated with plasma cell dyscrasias. Demyelination was not observed in nerves injected with anti-MAG and heated GPS or a monoclonal antibody to chick myoblasts and 20% GPS. These results establish the ability of anti-MAG to produce in vivo demyelination of mammalian CNS and indicate that a single antibody directed against a specific myelin component may initiate multiple types of myelin damage.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies / immunology
  • Antibodies / physiology*
  • Axons / ultrastructure
  • Guinea Pigs / blood
  • Mice
  • Mice, Inbred BALB C
  • Myelin Proteins / immunology*
  • Myelin Sheath / pathology*
  • Myelin Sheath / ultrastructure
  • Myelin-Associated Glycoprotein
  • Optic Nerve / pathology*
  • Optic Nerve / ultrastructure

Substances

  • Antibodies
  • Myelin Proteins
  • Myelin-Associated Glycoprotein